Pharmacy Medical News about bipolar disorder

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Longer-term treatment of patients with bipolar disorder: a 9-month observational study in Central and Eastern Europe, the Middle East and Africa
Current Medical Research and Opinion, 06/23/09

Okasha TA et al. - Inclusion of olanzapine is of benefit for pharmacological treatment of patients with bipolar disorder. However, the favourable outcomes observed cannot be directly attributed to olanzapine alone because of the high prevalence of polypharmacy in the patient population.

<< Previous
Cost-effectiveness of pegfilgrastim versus filgrastim primary...

Next >>
Prevention of vertebral fractures in osteoporosis: Mixed...

Stability of symptoms across major depressive episodes in bipolar disorder
Bipolar Disorders, 11/23/09 Relevance Score: 71%

The role of dopamine in bipolar disorder
Bipolar Disorders, 11/19/09 Relevance Score: 70%

Epidemiology and Management of Anxiety in Patients with Bipolar Disorder
CNS Drugs, 10/30/09 Relevance Score: 70%

Bipolar Disorder Patient Care Opportunities: Let's Answer the Call
Annals of Pharmacotherapy, 10/16/09 Relevance Score: 70%

Treatment of Bipolar Disorders and Metabolic Syndrome: Implications for Primary Care
Postgraduate Medicine, 10/15/09 Relevance Score: 70%